Name: X-Posts by @bryan_johnson (machine-readable)
License: https://creativecommons.org/licenses/by/4.0/

Bryan Johnson @bryan_johnson

I'm starting a new longevity protocol: microdosing Tirzepatide, a dual GLP-1/GIP receptor agonist.

Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention.
🧵